Clinical Trial Update: Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravitreal bevacizumab for diffuse diabetic macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Type 2 Diabetes Mellitus

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diabetes Mellitus Type 2, Diabetic Macular Edema | Phase 3 | Status: WITHDRAWN